WHO ICTRP trial
A clinical trial to study the effects of ZYH1 and Pioglitazone in patients with…
CTRI/2010/091/000167 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2010/091/000167 |
|---|---|
| Public title | A clinical trial to study the effects of ZYH1 and Pioglitazone in patients with high lipid levels and impaired glucose tolerance test. |
| Scientific title | A 12 week, randomized, double blind parallel group prospective dose ranging study of ZYH1 with an open pioglitazone arm to evaluate the efficacy on dyslipidemia in patients with Impaired Glucose tolerance Test. - NA |
| Primary sponsor | Cadila Healthcare Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: null- Dyslipidemia with Impaired Glucose Tolerance Test |
| Interventions | Intervention1: ZYH1 0.5mg, 1mg, 2mg and 4mg : one tablet once daily of either 0.5mg, 1mg, 2mg or 4mg in the morning for the entire duration of the study i.e. for 12 weeks. Control Intervention1: Pioglitazone (45 mg daily): Frequency-Once… |
| Registration date | Sep 3, 2010 |
| Target size | 30 |
| Secondary IDs | PROT No. 2004 Version 2 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: